Study of Leishmania pathogenesis in mice: Experimental considerations

Parasites and Vectors

Volumn 9, Issue 1, 2016, Pages

  Loeuillet, Corinne ^a   Bañuls, Anne Laure ^a   Hide, Mallorie ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Cutaneous; Dose; Inoculation site; Leishmaniases; Mice; Saliva; Visceral

Indexed keywords

EXPERIMENTAL MOUSE; GENETIC BACKGROUND; GENETIC STRAIN; GENOTYPE; HOST RESISTANCE; HUMAN; INOCULATION; LEISHMANIA; MOUSE; NONHUMAN; PARASITE VIRULENCE; PATHOGENESIS; REVIEW; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS; ANIMAL; DISEASE MODEL; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LEISHMANIASIS; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; VIRULENCE;

ANIMALS; DISEASE MODELS, ANIMAL; HOST-PATHOGEN INTERACTIONS; LEISHMANIA; LEISHMANIASIS; MICE; VIRULENCE;

EID: 84960930756     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-016-1413-9     Document Type: Review

References (83)

1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J, Jannin J, de Boer M: Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 2012;2012;7:1-12.
2. Bañuls AL, Hide M, Prugnolle F. Leishmania and the Leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol. 2007;64:1-109.
3. Bañuls a L, Bastien P, Pomares C, Arevalo J, Fisa R, Hide M. Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection. Clin Microbiol Infect. 2011;17:1451-61.
4. Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004;27:305-18.
5. Le Fichoux Y, Quaranta JF, Aufeuvre JP, Lelievre A, Marty P, Suffia I, Rousseau D, Kubar J. Occurrence of Leishmania infantum parasitemia in asymptomatic blood donors living in an area of endemicity in southern France. J Clin Microbiol. 1999;37:1953-7.
6. Hide M, Marion E, Pomares C, Fisa R, Marty P, Bañuls a L. Parasitic genotypes appear to differ in leishmaniasis patients compared with asymptomatic related carriers. Int J Parasitol. 2013;43:389-97.
7. Millán J, Ferroglio E, Solano-Gallego L. Role of wildlife in the epidemiology of Leishmania infantum infection in Europe. Parasitol Res. 2014;113(6):2005-14.
8. Ghawar W, Toumi A, Snoussi M-A, Chlif S, Zâatour A, Boukthir A, Hamida NBH, Chemkhi J, Diouani MF, Ben-Salah A. Leishmania major infection among Psammomys obesus and Meriones shawi: reservoirs of zoonotic cutaneous leishmaniasis in Sidi Bouzid (central Tunisia). Vector Borne Zoonotic Dis. 2011;11:1561-8.
9. Singh N, Mishra BB, Bajpai S, Singh RK, Tiwari VK. Natural product based leads to fight against leishmaniasis. Bioorg Med Chem. 2014;22(1):18-45.
10. Larréché S, Launay G, Weibel Galluzzo C, Bousquet A, Eperon G, Pilo J-E, Ravel C, Chappuis F, Dupin M, Mérens A. Cluster of zoonotic cutaneous leishmaniasis (Leishmania major) in European travelers returning from Turkmenistan. J Travel Med. 2013;20:400-2.
11. Mougneau E, Bihl F, Glaichenhaus N. Cell biology and immunology of Leishmania. Immunol Rev. 2011;240:286-96.
12. Blackwell JM, Fakiola M, Ibrahim ME, Jamieson SE, Jeronimo SB, Miller EN, Mishra A, Mohamed HS, Peacock CS, Raju M, Sundar S, Wilson ME. Genetics and visceral leishmaniasis: Of mice and man. Parasite Immunol. 2009;31(5):254-66.
13. Vidal S, Tremblay ML, Govoni G, Gauthier S, Sebastiani G, Malo D, Skamene E, Olivier M, Jothy S, Gros P. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med. 1995;182:655-66.
14. Bradley DJ, Taylor B a, Blackwell J, Evans EP, Freeman J. Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol. 1979;37:7-14.
15. Kaye PM, Svensson M, Ato M, Maroof A, Polley R, Stager S, Zubairi S, Engwerda CR. The immunopathology of experimental visceral leishmaniasis. Immunol Rev. 2004;201:239-53.
16. Blackwell JM. Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics. 1983;18:101-9.
17. Leclercq V, Lebastard M, Belkaid Y, Louis J, Milon G. The outcome of the parasitic process initiated by Leishmania infantum in laboratory mice: a tissue-dependent pattern controlled by the Lsh and MHC loci. J Immunol. 1996;157:4537-45.
18. Engwerda CR, Kaye PM. Organ-specific immune responses associated with infectious disease. Immunol Today. 2000;21:73-8.
19. Melby PC, Tabares a, Restrepo BI, Cardona a E, McGuff HS, Teale JM. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection. Exp Parasitol. 2001;99:17-25.
20. Smelt SC, Engwerda CR, McCrossen M, Kaye PM. Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J Immunol. 1997;158:3813-21.
21. Murray HW, Stern JJ, Welte K, Carriero SM, Nathan a NDCF, Rubin Y. Treatment With Interleukin 2 and Interferon- $. J Immunol. 1987;138:2290-7.
22. Kaye PM, Curry a J, Blackwell JM. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J Immunol. 1991;146:2763-70.
23. Nascimento MSL, Carregaro V, Lima-Júnior DS, Costa DL, Ryffel B, Duthie MS, de Jesus A, de Almeida RP, da Silva JS. Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection. J Infect Dis. 2015;211:1015-26.
24. Rodrigues OR, Marques C, Soares-Clemente M, Ferronha MH, Santos-Gomes GM. Identification of regulatory T cells during experimental Leishmania infantum infection. Immunobiology. 2009;214:101-11.
25. Gomes-Pereira S, Rodrigues OR, Rolão N, Almeida PD, Santos-Gomes GM. Hepatic cellular immune responses in mice with "cure" and "non-cure" phenotype to Leishmania infantum infection: Importance of CD8+ T cells and TGF-β production. FEMS Immunol Med Microbiol. 2004;41:59-68.
26. Squires KE, Kirsch M, Silverstein SC, Acosta A, McElrath MJ, Murray HW. Defect in the tissue cellular immune response: Experimental visceral leishmaniasis in euthymic C57BL/6 ep/ep mice. Infect Immun. 1990;58:3893-8.
27. Sulahian A, Garin YJF, Pratlong F, Dedet JP, Derouin F. Experimental pathogenicity of viscerotropic and dermotropic isolates of Leishmania infantum from immunocompromised and immunocompetent patients in a murine model. FEMS Immunol Med Microbiol. 1997;17:131-8.
28. Honoré S, Garin YJF, Sulahian A, Gangneux JP, Derouin F. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection. FEMS Immunol Med Microbiol. 1998;21:231-9.
29. Gangneux JP, Sulahian A, Honore S, Meneceur P, Derouin F, Garin YJF. Evidence for determining parasitic factors in addition to host genetics and immune status in the outcome of murine Leishmania infantum visceral leishmaniasis. Parasite Immunol. 2000;22:515-9.
30. Baptista-Fernandes T, Marques C, Roos Rodrigues O, Santos-Gomes GM. Intra-specific variability of virulence in Leishmania infantum zymodeme MON-1 strains. Comp Immunol Microbiol Infect Dis. 2007;30:41-53.
31. Garin YJF, Sulahian a., Pratlong F, Meneceur P, Gangneux JP, Prina E, Dedet JP, Derouin F. Virulence of Leishmania infantum is expressed as a clonal and dominant phenotype in experimental infections. Infect Immun. 2001;69:7365-73.
32. Rosypal AC, Zajac AM, Troy GC, Lindsay DS. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum. Vet Parasitol. 2005;130:19-27.
33. Oliveira DM, Costa MAF, Chavez-Fumagalli M a., Valadares DG, Duarte MC, Costa LE, Martins VT, Gomes RF, Melo MN, Soto M, Tavares CAP, Coelho EAF. Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB/c mice using different doses and routes of inoculation of parasites. Parasitol Res. 2012;110:1277-85.
34. Kaur S, Kaur T, Garg N, Mukherjee S, Raina P, Athokpam V. Effect of dose and route of inoculation on the generation of CD4 + Th1/Th2 type of immune response in murine visceral leishmaniasis. Parasitol Res. 2008;103:1413-9.
35. Mukherjee P, Ghosh AK, Ghose AC. Infection pattern and immune response in the spleen and liver of BALB/c mice intracardially infected with Leishmania donovani amastigotes. Immunol Lett. 2003;86:131-8.
36. Carrión J, Nieto a., Iborra S, Iniesta V, Soto M, Folgueira C, Abanades DR, Requena JM, Alonso C. Immunohistological features of visceral leishmaniasis in BALB/c mice. Parasite Immunol. 2006;28:173-83.
37. Rolão N, Melo C, Campino L. Influence of the inoculation route in BALB/c mice infected by Leishmania infantum. Acta Trop. 2004;90:123-6.
38. Ahmed S, Colmenares M, Soong L, Goldsmith-Pestana K, Munstermann L, Molina R, McMahon-Pratt D. Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun. 2003;71:401-10.
39. Oliveira F, de Carvalho AM, de Oliveira CI. Sand-fly saliva-Leishmania-man: The trigger trio. Front Immunol. 2013;4(NOV):1-8.
40. Paranhos M, dos Santos WC, Sherlock I, Oliveira GG, de Carvalho LC. Development of eosinophilia in dogs intradermically inoculated with sand fly saliva and Leishmania (Leishmania) chagasi stationary-phase promastigotes. Mem Inst Oswaldo Cruz. 1993;88:249-51.
41. Dedet JP, Pratlong F, Lanotte G, Ravel C. Cutaneous leishmaniasis. The parasite. Clin Dermatol. 1999;17:261-8.
42. DeTolla LJ, Scott PA, Farrell JP. Single gene control of resistance to cutaneous leishmaniasis in mice. Immunogenetics. 1981;14:29-39.
43. Fortier AH, Meltzer MS, Nacy CA. Susceptibility of inbred mice to Leishmania tropica infection: genetic control of the development of cutaneous lesions in P/J mice. J Immunol. 1984;133:454-9.
44. Mock B a, Fortier a H, Potter M, Nacy C a. Genetic control of systemic Leishmania major infections: Dissociation of intrahepatic amastigote replication from control by the Lsh gene. Infect Immun. 1985;50:588-91.
45. Davies EV, Singleton AMT, Blackwell JM. Differences in Lsh gene control over systemic Leishmania major and Leishmania donovani or Leishmania mexicana infections are caused by differential targeting to infiltrating and resident liver macrophage populations. Infect Immun. 1988;56:1128-34.
46. Howard JG, Hale C, Chan-Liew WL. Immunological regulation of experimental cutaneous leishmaniasis. 1. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 1980;2:303-14.
47. Mitchell GF, Curtis JM, Handman E. Resistance to cutaneous leishmaniasis in genetically susceptible BALB/c mice. Aust J Exp Biol Med Sci. 1981;59(Pt 5):555-65.
48. Roberts M, Alexander J, Blackwell JM. Influence of Lsh, H-2, and an H-11-linked gene on visceralization and metastasis associated with Leishmania mexicana infection in mice. Infect Immun. 1989;57:875-81.
49. Blackwell JM. Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology. 1996;112(Suppl):S67-74.
50. Foote SJ, Handman E. Genetics of murine leishmaniasis. Brief Funct Genomic Proteomic. 2005;4:270-6.
51. Sakthianandeswaren A, Foote SJ, Handman E. The role of host genetics in leishmaniasis. Trends Parasitol. 2009;25:383-91.
52. Kurey I, Kobets T, Havelková H, Slapničková M, Quan L, Trtková K, Grekov I, Svobodová M, Stassen AP, Hutson A, Demant P, Lipoldová M. Distinct genetic control of parasite elimination, dissemination, and disease after Leishmania major infection. Immunogenetics. 2009;61:619-33.
53. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002;2:845-58.
54. Belkaid Y, Piccirillo C a, Mendez S. CD4 1 CD25 1 regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420(September):633-7.
55. Belkaid Y. The role of CD4(+)CD25(+) regulatory T cells in Leishmania infection. Expert Opin Biol Ther. 2003;3:875-85.
56. Lopez Kostka S, Dinges S, Griewank K, Iwakura Y, Udey MC, von Stebut E. IL-17 promotes progression of cutaneous leishmaniasis in susceptible mice. J Immunol. 2009;182:3039-46.
57. Lima HC, Titus RG. Effects of sand fly vector saliva on development of cutaneous lesions and the immune response to Leishmania braziliensis in BALB/c mice. Infect Immun. 1996;64:5442-5.
58. Belkaid Y, Mendez S, Lira R, Kadambi N, Milon G, Sacks D. A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity. J Immunol. 2000;165:969-77.
59. Mcelrath BMJ, Kaplan G, Nusrat A, Cohn ZA: The Defect in T Cell Influx in BALB/c Mice. J Exp Med. 1987;165:546-59.
60. Cangussú SD, de Souza CC, Campos CF, Vieira LQ, Afonso LCC, Arantes RME. Histopathology of Leishmania major infection: Revisiting L. major histopathology in the ear dermis infection model. Mem Inst Oswaldo Cruz. 2009;104:918-22.
61. Müller K, van Zandbergen G, Hansen B, Laufs H, Jahnke N, Solbach W, Laskay T. Chemokines, natural killer cells and granulocytes in the early course of Leishmania major infection in mice. Med Microbiol Immunol. 2001;190:73-6.
62. Li J, Nolan TJ, Farrell JP. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone. Exp Parasitol. 1997;87:47-57.
63. Kébaïer C, Louzir H, Chenik M, Ben Salah A, Dellagi K. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response. Infect Immun. 2001;69:4906-15.
64. Markikou-Ouni W, Ben Achour-Chenik Y, Meddeb-Garnaoui a. Effects of Leishmania major clones showing different levels of virulence on infectivity, differentiation and maturation of human dendritic cells. Clin Exp Immunol. 2012;169:273-80.
65. Alimohammadian MH, Darabi H, Ajdary S, Khaze V, Torkabadi E. Genotypically distinct strains of Leishmania major display diverse clinical and immunological patterns in BALB/c mice. Infect Genet Evol. 2010;10:969-75.
66. Asadpour A, Riazi-Rad F, Khaze V, Ajdary S, Alimohammadian MH. Distinct strains of Leishmania major induce different cytokine mRNA expression in draining lymph node of BALB/c mice. Parasite Immunol. 2013;35:42-50.
67. Menon JN, Bretscher P a. Parasite dose determines the Th1/Th2 nature of the response to Leishmania major independently of infection route and strain of host or parasite. Eur J Immunol. 1998;28:4020-8.
68. Bretscher PA, Wei G, Menon JN, Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major. Science. 1992;257:539-42.
69. Uzonna JE, Wei G, Yurkowski D, Bretscher P. Immune elimination of Leishmania major in mice: implications for immune memory, vaccination, and reactivation disease. J Immunol. 2001;167:6967-74.
70. Doherty TM, Coffman RL. Leishmania major: effect of infectious dose on T cell subset development in BALB/c mice. Exp Parasitol. 1996;84:124-35.
71. Uzonna JE, Joyce KL, Scott P. Low dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cells. J Exp Med. 2004;199:1559-66.
72. Lira R, Doherty M, Modi G, Sacks D. Evolution of lesion formation, parasitic load, immune response, and reservoir potential in C57BL/6 mice following high- and low-dose challenge with Leishmania major. Infect Immun. 2000;68:5176-82.
73. Nabors GS, Farrell JP. Site-specific immunity to Leishmania major in SWR mice: The site of infection influences susceptibility and expression of the antileishmanial immune response. Infect Immun. 1994;62:3655-62.
74. Baldwin TM, Elso C, Curtis J, Buckingham L, Handman E: The Site of Leishmania major Infection Determines Disease Severity and Immune Responses. Infect Immun. 2003;71:1-6.
75. Titus RG, Ribeiro JM. Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity. Science. 1988;239:1306-8.
76. Theodos CM, Ribeiro JMC, Titus RG. Analysis of enhancing effect of sand fly saliva on Leishmania infection in mice. Infect Immun. 1991;59:1592-8.
77. Norsworthy NB, Sun J, Elnaiem D, Lanzaro G, Soong L. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun. 2004;72:1240-7.
78. Carregaro V, Costa DL, Brodskyn C, Barral AM, Barral-Netto M, Cunha FQ, Silva JS. Dual effect of Lutzomyia longipalpis saliva on Leishmania braziliensis infection is mediated by distinct saliva-induced cellular recruitment into BALB/c mice ear. BMC Microbiol. 2013;13:102.
79. Morris RV, Shoemaker CB, David JR, Lanzaro GC, Titus RG. Sandfly maxadilan exacerbates infection with Leishmania major and vaccinating against it protects against L. major infection. J Immunol. 2001;167:5226-30.
80. Mbow ML, Bleyenberg JA, Hall LR, Titus RG. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major. J Immunol. 1998;161:5571-7.
81. Belkaid Y, Kamhawi S, Modi G, Valenzuela J, Noben-Trauth N, Rowton E, Ribeiro J, Sacks DL. Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis. J Exp Med. 1998;188:1941-53.
82. Lang T, Courret N, Colle JH, Milon G, Antoine JC. The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum. Infect Immun. 2003;71:2674-83.
83. van Zandbergen G, Bollinger A, Wenzel A, Kamhawi S, Voll R, Klinger M, Müller A, Hölscher C, Herrmann M, Sacks D, Solbach W, Laskay T. Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum. Proc Natl Acad Sci U S A. 2006;103:13837-42.